Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


LightCycler® Software 4.1

Product Description
Conforms to the European directive for in vitro diagnostic medical devices 98/79/EC in combination with the LightCycler® 2.0 Instrument.

The LightCycler® Software 4.1 is an update to LightCycler® Software 4.05. The only difference between this updated version and LightCycler® Software 4.05 is that Version 4.1 can be operated on Windows XP. It integrates all software modules required to perform and analyze any type of experiment using the LightCycler® 2.0 Instrument.
Opening new horizons in the field of data analysis, the LightCycler® Software 4.1 maintains and expands the analysis modules for absolute quantification and melting curve analysis. Additionally, the new software integrates a dedicated relative quantification module for mono- and dual-color experiments. A module for genotyping by melting curve analysis is also part of the package. Most analysis modules automate the analysis of internal controls.
The LightCycler® Software 4.1, as well as LightCycler® Software 4.05, offers a new quality of data management, user management, and security.

Analysis modules of LightCycler® Software 4.1

Quantification:

Absolute quantification
Relative quantification
Qualitative analysis

Melting Curve Analysis:

Tm Calling
Genotyping

Other:

Determination of nucleic acid concentration

Product LightCycler® Software 4.1
Company Roche - Products Listing
Price Request a quote
More Information View company product page
Catalog Number 04898915001
Quantity 1
Company Logo

Roche - Products Listing
Roche Diagnostics Corporation Roche Applied Science P.O. Box 50414 9115 Hague Road Indianapolis, IN 46250-0414 US

Tel: +1-800-428-5433
Fax: +1-800-428-2883



Scientific News
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
New Imaging Method Reveals Nanoscale Details about DNA
Enhancement to super-resolution microscopy shows orientation of individual molecules, providing a new window into DNA’s structure and dynamics.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Scoliosis Linked to Disruptions in Spinal Fluid Flow
A new study in zebrafish suggests that irregular fluid flow through the spinal column brought on by gene mutations is linked to a type of scoliosis that can affect humans during adolescence.
A New Tool Brings Personalized Medicine Closer
Scientists from EPFL and ETHZ have developed a powerful tool for exploring and determining the inherent biological differences between individuals, which overcomes a major hurdle for personalized medicine.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!